Research Technologies

Genentech as part of the Roche Group is at the forefront when it comes to collaboration with biotechs at all development stages to drive the application of technology and modality platforms that have the potential to transform discovery as well as generate innovative medicines beyond the standard of care.

Partnering opportunities we are looking for:

• Novel modalities and enabling technologies (e.g., Genomic Medicines, Degraders, Discovery platforms)
• Targeted or intracellular delivery
• Artificial intelligence for target and drug discovery

Example partnerships

Recursion – research collaboration with Roche and Genentech to use machine learning and high content screening methods at scale to map complex biology in neuroscience and oncology

Skyhawk – research collaboration to discover and develop small molecule RNA splicing modifiers for oncology and neurodegenerative diseases

Bicycle Therapeutics – research collaboration to discover and develop immunomodulatory bicyclic peptides for the treatment of cancer

Your dedicated partnering leads in Research Technologies

Barbara Lueckel, Head of Research Technologies, Pharma Partnering

Tomas Hejhal, Search & Evaluation Lead Research Technologies, Pharma Partnering